Felix Beuschlein

Felix Beuschlein's AcademicInfluence.com Rankings

Felix Beuschlein

Philosophy

#8253

World Rank

#11595

Historical Rank

Logic

#5286

World Rank

#6673

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Felix Beuschlein's Degrees

Doctorate Medicine University of Zurich
PhD Endocrinology University of Zurich

Why Is Felix Beuschlein Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Felix Beuschlein's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The Immune Landscape of Cancer (2018) (2766)
Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
Evidence for two types of brown adipose tissue in humans (2013) (592)
Integrated genomic characterization of adrenocortical carcinoma (2014) (519)
Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. (2017) (473)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension (2013) (464)
Mutations in the deubiquitinase gene USP8 cause Cushing's disease (2014) (412)
Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma (2009) (409)
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome. (2014) (320)
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. (2016) (295)
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (284)
Combination chemotherapy in advanced adrenocortical carcinoma. (2012) (275)
High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. (2015) (272)
Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. (2015) (244)
Prevalence, Clinical, and Molecular Correlates of KCNJ5 Mutations in Primary Aldosteronism (2012) (242)
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. (2016) (241)
Genetic Spectrum and Clinical Correlates of Somatic Mutations in Aldosterone-Producing Adenoma (2014) (240)
Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. (2009) (239)
Observational Study Mortality in Treated Primary Aldosteronism: The German Conn's Registry (2012) (211)
High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. (2010) (207)
Adrenal Venous Sampling: Evaluation of the German Conn's Registry (2011) (195)
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism (2017) (176)
Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma. (2009) (174)
Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. (2015) (172)
KCNJ5 Mutations in European Families With Nonglucocorticoid Remediable Familial Hyperaldosteronism (2012) (171)
SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T) (2015) (167)
Risk factors associated with a low glomerular filtration rate in primary aldosteronism. (2009) (156)
High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. (2009) (154)
The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease. (2015) (149)
Clinical review: Outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review. (2013) (146)
Automated chemiluminescence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps. (2006) (145)
Clonal composition of human adrenocortical neoplasms. (1994) (138)
Somatic ATP1A1, ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas (2014) (132)
Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5α-reductase, explaining the need for personalized glucocorticoid and androgen replacement. (2013) (130)
The role of surgery in the management of recurrent adrenocortical carcinoma. (2013) (128)
The ACE-2 in COVID-19: Foe or Friend? (2020) (120)
Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas (2016) (116)
ARMC5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia: Clinical and Functional Consequences. (2015) (113)
Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas/paragangliomas due to succinate dehydrogenase deficiency. (2014) (112)
Subclinical hypercortisolism: a state, a syndrome, or a disease? (2015) (109)
Mass Spectrometry-Based Adrenal and Peripheral Venous Steroid Profiling for Subtyping Primary Aldosteronism. (2016) (109)
Deletion of the adrenocorticotropin receptor gene in human adrenocortical tumors: implications for tumorigenesis. (1997) (107)
ACTH-receptor expression, regulation and role in adrenocortial tumor formation. (2001) (105)
Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. (2012) (101)
Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas (2017) (98)
Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry. (2010) (97)
Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated O-Methylated Catecholamine Metabolites. (2018) (97)
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. (2015) (96)
Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature. (2014) (95)
Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatographytandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma (2013) (95)
Steroidogenic factor-1 is essential for compensatory adrenal growth following unilateral adrenalectomy. (2002) (95)
Biochemical diagnosis of phaeochromocytoma using plasma‐free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions (2014) (95)
Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment. (2007) (94)
Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. (2007) (92)
Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. (2012) (90)
Ectopic pro-opiomelanocortin syndrome. (2002) (90)
Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. (2011) (90)
Novel somatic mutations in the catalytic subunit of the protein kinase A as a cause of adrenal Cushing's syndrome: a European multicentric study. (2014) (89)
Discerning malignancy in adrenocortical tumors: are molecular markers useful? (2001) (89)
COVID-19 and metabolic disease: mechanisms and clinical management (2021) (88)
Interaction between Dax-1 and steroidogenic factor-1 in vivo: increased adrenal responsiveness to ACTH in the absence of Dax-1. (2002) (88)
Mitotane Monotherapy in Patients With Advanced Adrenocortical Carcinoma (2018) (87)
Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism. (2014) (86)
Adrenal 20alpha-hydroxysteroid dehydrogenase in the mouse catabolizes progesterone and 11-deoxycorticosterone and is restricted to the X-zone. (2007) (86)
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study. (2019) (83)
Simultaneous liquid chromatography tandem mass spectrometric determination of urinary free metanephrines and catecholamines, with comparisons of free and deconjugated metabolites. (2013) (82)
Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma. (2000) (82)
Neuroendocrine tumor recurrence: diagnosis with 68Ga-DOTATATE PET/CT. (2013) (82)
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma (2018) (80)
Diagnosis of primary aldosteronism: value of different screening parameters and influence of antihypertensive medication. (2004) (79)
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study (2020) (79)
Activin Induces x-Zone Apoptosis That Inhibits Luteinizing Hormone-Dependent Adrenocortical Tumor Formation in Inhibin-Deficient Mice (2003) (79)
Aldosterone excess impairs first phase insulin secretion in primary aldosteronism. (2013) (77)
Total adrenal volume but not testicular adrenal rest tumor volume is associated with hormonal control in patients with 21-hydroxylase deficiency. (2010) (76)
Favorable long-term outcomes of bilateral adrenalectomy in Cushing's disease. (2014) (76)
High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. (2003) (76)
Quality of life is less impaired in adults with congenital adrenal hyperplasia because of 21‐hydroxylase deficiency than in patients with primary adrenal insufficiency (2011) (76)
Life-threatening events in patients with pheochromocytoma. (2015) (75)
Commentary on the Endocrine Society Practice Guidelines: Consequences of adjustment of antihypertensive medication in screening of primary aldosteronism (2011) (75)
Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation. (2005) (75)
[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes. (2008) (74)
International histopathology consensus for unilateral primary aldosteronism. (2020) (74)
Major Role of Cathepsin L for Producing the Peptide Hormones ACTH, β-Endorphin, and α-MSH, Illustrated by Protease Gene Knockout and Expression* (2008) (73)
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism (2018) (72)
Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma (2017) (72)
Expression of adrenocorticotrophic hormone receptor mRNA in human adrenocortical neoplasms: correlation with P450scc expression (1997) (70)
Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. (2010) (70)
Adrenocortical carcinoma — towards genomics guided clinical care (2019) (70)
A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome. (2015) (70)
Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. (2012) (64)
PKA catalytic subunit mutations in adrenocortical Cushing’s adenoma impair association with the regulatory subunit (2014) (63)
Screening for membrane hormone receptor expression in primary aldosteronism. (2009) (63)
Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism. (2012) (63)
Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits (2010) (62)
Time to recovery of adrenal function after curative surgery for Cushing's syndrome depends on etiology. (2015) (62)
Testicular adrenal rest tumors develop independently of long-term disease control: a longitudinal analysis of 50 adult men with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency. (2013) (62)
Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study (2014) (60)
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. (2020) (59)
Deficits in the management of patients with adrenocortical carcinoma in Germany. (2010) (58)
Personalized Management of Pheochromocytoma and Paraganglioma (2021) (58)
ACTH-dependent regulation of microRNA as endogenous modulators of glucocorticoid receptor expression in the adrenal gland. (2012) (58)
Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas Without PRKACA p.Leu206Arg Mutation. (2016) (56)
DNA Methylation Is an Independent Prognostic Marker of Survival in Adrenocortical Cancer. (2016) (56)
Characterization of an adrenocorticotropin (ACTH) receptor promoter polymorphism leading to decreased adrenal responsiveness to ACTH. (2004) (55)
Association of plasma aldosterone with the metabolic syndrome in two German populations. (2011) (55)
The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry. (2009) (55)
Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. (2006) (55)
DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. (1998) (55)
Pre-B-cell transcription factor 1 and steroidogenic factor 1 synergistically regulate adrenocortical growth and steroidogenesis. (2007) (55)
Erratum: Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma (Cancer Cell (2016) 29(5) (723–736) (S153561081630160X) (10.1016/j.ccell.2016.04.002)) (2016) (54)
Plasma Steroid Metabolome Profiling for Diagnosis and Subtyping Patients with Cushing Syndrome. (2018) (54)
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics. (2017) (53)
Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas. (2014) (53)
DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers (2015) (53)
Contemporary microsurgical concept for the treatment of Cushing’s disease: endocrine outcome in 83 consecutive patients (2012) (52)
Steroid 21-hydroxylase mutations and 21-hydroxylase messenger ribonucleic acid expression in human adrenocortical tumors. (1998) (52)
Persistence of myopathy in Cushing's syndrome: evaluation of the German Cushing's Registry. (2017) (51)
Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms (2001) (51)
Localization and expression of adrenocorticotropic hormone receptor mRNA in normal and neoplastic human adrenal cortex. (1998) (51)
Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R. (2008) (51)
Efficacy and acceptability of lanreotide Autogel® 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR. (2010) (50)
Adrenal cortical insufficiency--a life threatening illness with multiple etiologies. (2013) (50)
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma (2018) (50)
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features: data from a multi-institutional series. (2014) (50)
Impaired Glucose Metabolism in Primary Aldosteronism Is Associated With Cortisol Cosecretion. (2019) (49)
Diabetic polyneuropathy is associated with respiratory muscle impairment in type 2 diabetes (2007) (49)
Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma (2018) (48)
New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line (2000) (47)
SF-1, DAX-1, AND ACD: MOLECULAR DETERMINANTS OF ADRENOCORTICAL GROWTH AND STEROIDOGENESIS (2002) (47)
Immunohistopathology and Steroid Profiles Associated With Biochemical Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism (2018) (47)
Silencing Mutated β-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R (2013) (46)
Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone. (2012) (46)
Timelines in the management of adrenal crisis – targets, limits and reality (2015) (46)
Cellular Pathophysiology of an Adrenal Adenoma-Associated Mutant of the Plasma Membrane Ca(2+)-ATPase ATP2B3. (2016) (45)
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients (2018) (45)
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma (2019) (44)
Bone morphogenetic proteins 2 and 5 are down-regulated in adrenocortical carcinoma and modulate adrenal cell proliferation and steroidogenesis. (2009) (44)
Frequency and clinical correlates of somatic Ying Yang 1 mutations in sporadic insulinomas. (2015) (44)
Somatic ATP 1 A 1 , ATP 2 B 3 , and KCNJ 5 Mutations in Aldosterone-Producing Adenomas (43)
AKT is highly phosphorylated in pheochromocytomas but not in benign adrenocortical tumors. (2005) (43)
Value of Molecular Classification for Prognostic Assessment of Adrenocortical Carcinoma. (2019) (42)
Time to diagnosis in Cushing's syndrome: A meta-analysis based on 5367 patients. (2020) (41)
Sexual dimorphism in COVID-19: potential clinical and public health implications (2022) (40)
An Update on Addison’s Disease (2018) (40)
Targeting heterogeneity of adrenocortical carcinoma: Evaluation and extension of preclinical tumor models to improve clinical translation (2016) (40)
Pheochromocytoma and paraganglioma: Clinical feature based disease probability in relation to catecholamine biochemistry and reason for disease suspicion. (2019) (39)
Gonadectomy in mice of the inbred strain CE/J induces proliferation of sub-capsular adrenal cells expressing gonadal marker genes. (2006) (39)
Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine. (2019) (39)
Pituicytoma in a patient with Cushing’s disease: case report and review of the literature (2012) (39)
A highly sensitive immunofluorometric assay for the measurement of aldosterone in small sample volumes: validation in mouse serum. (2008) (38)
Linear and volumetric evaluation of the adrenal gland--MDCT-based measurements of the adrenals. (2014) (38)
Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor. (2018) (38)
Steroidogenic acute regulatory protein mRNA expression in adrenal tumours. (2000) (37)
Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma (2010) (37)
Presence of brown adipocytes in retroperitoneal fat from patients with benign adrenal tumors: relationship with outdoor temperature. (2013) (36)
Long-Term Outcome of Primary Bilateral Macronodular Adrenocortical Hyperplasia After Unilateral Adrenalectomy. (2019) (36)
Regulation of aldosterone secretion: from physiology to disease (2013) (35)
Expression and spatio-temporal distribution of differentiation and proliferation markers during mouse adrenal development. (2007) (35)
Toward a Diagnostic Score in Cushing's Syndrome (2019) (35)
Regulation of aldosterone secretion: from physiology to disease. (2013) (35)
Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy (2018) (35)
Aminoglutethimide suppresses adrenocorticotropin receptor expression in the NCI-h295 adrenocortical tumor cell line. (1998) (34)
PRKACA Somatic Mutations Are Rare Findings in Aldosterone-Producing Adenomas. (2016) (33)
Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone production. (2006) (32)
CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease. (2009) (32)
A high aldosterone to renin ratio is associated with high serum parathyroid hormone concentrations in the general population. (2014) (31)
cAMP signaling in cortisol-producing adrenal adenoma. (2015) (31)
Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma (2017) (31)
Potent antitumor activity of the novel HSP90 inhibitors AUY922 and HSP990 in neuroendocrine carcinoid cells (2013) (31)
The SPARTACUS Trial: Controversies and Unresolved Issues (2017) (30)
Urine Steroid Metabolomics as a Novel Tool for Detection of Recurrent Adrenocortical Carcinoma (2019) (30)
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. (2020) (30)
Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation (2021) (29)
Consequences of the COVID-19 pandemic for patients with metabolic diseases (2021) (29)
Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism (2020) (29)
Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma (2015) (29)
Molecular adrenocortical tumourigenesis (2000) (28)
The Prevalence of Familial Hyperaldosteronism in Apparently Sporadic Primary Aldosteronism in Germany: a Single Center Experience (2012) (28)
Cushing’s syndrome: a model for sarcopenic obesity (2017) (27)
Intraoperative haemodynamic stability in patients with phaeochromocytoma – minimally invasive vs conventional open surgery (2006) (27)
Cortisol Producing Adrenal Adenoma—a New Manifestation of Gardner's Syndrome (2000) (27)
ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test. (2015) (27)
Spontaneous remission of idiopathic aldosteronism after long‐term treatment with spironolactone: results from the German Conn’s Registry (2012) (27)
Post-saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism. (2015) (26)
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors (2022) (26)
Levodopa therapy in Parkinson’s disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine (2014) (26)
COVID-19 targets human adrenal glands (2021) (26)
Plasma steroid profiles in subclinical compared to overt adrenal Cushing's syndrome. (2019) (26)
Hair Glucocorticoids as a Biomarker for Endogenous Cushing’s Syndrome: Validation in Two Independent Cohorts (2019) (25)
Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutations. (2019) (25)
ACTH 1-24 inhibits proliferation of adrenocortical tumors in vivo. (2005) (25)
The role of regulated necrosis in endocrine diseases (2021) (24)
Evaluation of a standardized protocol for processing adrenal tumor samples: preparation for a European adrenal tumor bank. (2010) (24)
Fabry disease genotype, phenotype, and migalastat amenability: Insights from a national cohort (2019) (24)
Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors. (2000) (24)
Primary aldosteronism: key characteristics at diagnosis: a trend toward milder forms. (2018) (23)
Classification of microadenomas in patients with primary aldosteronism by steroid profiling (2019) (23)
In situ metabolomics of aldosterone-producing adenomas. (2019) (23)
Liposomal polychemotherapy improves adrenocortical carcinoma treatment in a preclinical rodent model. (2014) (23)
β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis (2020) (22)
Role of the inhibin/activin system and luteinizing hormone in adrenocortical tumorigenesis. (2004) (22)
Characterization of NCI-H295R Cells as an In Vitro Model of Hyperaldosteronism (2012) (22)
ARMC 5 Mutations in a Large Cohort of Primary Macronodular Adrenal Hyperplasia : Clinical and Functional Consequences (2015) (22)
Anti insulin-like growth factor I receptor immunoliposomes: a single formulation combining two anticancer treatments with enhanced therapeutic efficiency. (2010) (22)
Current management and outcome of pregnancies in women with adrenal insufficiency: experience from a multi-center survey. (2020) (21)
Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism - long-term outcome and clinical impact. (2019) (21)
Low-dose glucose infusion after achieving critical hypoglycemia during insulin tolerance testing: effects on time of hypoglycemia, neuroendocrine stress response and patient's discomfort in a pilot study. (2005) (21)
Isoenergetic Feeding of Low Carbohydrate-High Fat Diets Does Not Increase Brown Adipose Tissue Thermogenic Capacity in Rats (2012) (21)
Association between 25-Hydroxyvitamin D Status and Components of Body Composition and Glucose Metabolism in Older Men and Women (2018) (21)
Links between aldosterone excess and metabolic complications: A comprehensive review. (2020) (21)
A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: Validation in human and mouse plasma (2010) (21)
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance. (2018) (20)
Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo (2018) (20)
MANAGEMENT OF ENDOCRINE DISEASE: Fertility, pregnancy and lactation in women with adrenal insufficiency. (2018) (20)
Metabolic Alterations in Patients with Pheochromocytoma (2018) (20)
Lack of influence of somatic mutations on steroid gradients during adrenal vein sampling in aldosterone-producing adenoma patients. (2013) (20)
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas. (2020) (20)
Therapeutic options after surgical failure in Cushing's disease: A critical review. (2019) (20)
Liposomal doxorubicin-based treatment in a preclinical model of adrenocortical carcinoma. (2012) (20)
Animal models of adrenocortical tumorigenesis (2012) (20)
Histopathological and genetic characterization of aldosterone-producing adenomas with concurrent subclinical cortisol hypersecretion: a case series (2017) (20)
Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease? (2018) (19)
Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas (2017) (19)
Immunohistochemical expression of stem cell markers in pheochromocytomas/paragangliomas is associated with SDHx mutations. (2015) (19)
Surviving ectopic Cushing's syndrome: quality of life, cardiovascular and metabolic outcomes in comparison to Cushing's disease during long-term follow-up. (2018) (19)
Preclinical progress and first translational steps for a liposomal chemotherapy protocol against adrenocortical carcinoma. (2016) (19)
Impact of 123 I-MIBG scintigraphy on clinical decision making in pheochromocytoma and paraganglioma. (2019) (19)
Genetic influence of an ACTH receptor promoter polymorphism on adrenal androgen secretion. (2005) (19)
Optimizing Genetic Workup in Pheochromocytoma and Paraganglioma by Integrating Diagnostic and Research Approaches (2019) (19)
RNA-Sequencing and Somatic Mutation Status of Adrenocortical Tumors: Novel Pathogenetic Insights. (2020) (19)
Proteomic Landscape of Aldosterone-Producing Adenoma (2019) (18)
Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease (2021) (18)
Cortisol-related metabolic alterations assessed by mass spectrometry assay in patients with Cushing's syndrome. (2017) (17)
Aldosterone producing adrenal adenomas are characterized by activation of calcium/calmodulin-dependent protein kinase (CaMK) dependent pathways. (2011) (17)
Plasma metanephrines and prospective prediction of tumor location, size and mutation type in patients with pheochromocytoma and paraganglioma (2020) (17)
Synergistic Highly Potent Targeted Drug Combinations in different Pheochromocytoma Models including Human Tumor Cultures. (2019) (17)
The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2‐Year Follow‐Up Study (2020) (17)
Short term regulation of aldosterone secretion after stimulation and suppression experiments in mice. (2009) (17)
KCNJ5 Mutations: Sex, Salt and Selection (2015) (17)
TNF alpha signaling is associated with therapeutic responsiveness to vascular disrupting agents in endocrine tumors (2016) (16)
The impact of Connshing's syndrome - mild cortisol excess in primary aldosteronism drives diabetes risk. (2017) (16)
Role of bone morphogenetic proteins in adrenal physiology and disease. (2010) (16)
Tumor size of Conn's adenoma and comorbidities. (2009) (16)
Worsening of lipid metabolism after successful treatment of primary aldosteronism (2015) (16)
Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma. (2014) (16)
The cardiovascular markers copeptin and high-sensitive C-reactive protein decrease following specific therapy for primary aldosteronism (2016) (16)
Diverse Responses of Autoantibodies to the Angiotensin II Type 1 Receptor in Primary Aldosteronism. (2019) (16)
Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma. (2020) (16)
ERCC1 as predictive biomarker to platinum-based chemotherapy in adrenocortical carcinomas. (2018) (15)
Advances in adrenal tumors 2018 (2018) (15)
Expression and mutational status of USP8 in tumors causing ectopic ACTH secretion syndrome. (2017) (15)
Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas (2020) (15)
Performance of LC–MS/MS and immunoassay based 24-h urine free cortisol in the diagnosis of Cushing's syndrome (2019) (15)
Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission (2020) (14)
Diastrophic Dysplasia Sulfate Transporter (SLC26A2) Is Expressed in the Adrenal Cortex and Regulates Aldosterone Secretion (2014) (14)
The TALE homeodomain of PBX1 is involved in human primary testis‐determination (2019) (14)
THERAPY OF ENDOCRINE DISEASE: Medical treatment of primary aldosteronism. (2019) (14)
Primary adrenal lymphoma: 3 case reports with different outcomes. (2011) (14)
Adrenal Incidentalomas: Presentation and Clinical Work-Up (2007) (14)
Steroidogenic acute regulatory (StAR)-directed immunotherapy protects against tumor growth of StAR-expressing Sp2-0 cells in a rodent adrenocortical carcinoma model. (2004) (14)
Intracranial germinoma as a very rare cause of panhypopituitarism in a 23-year old man. (2008) (14)
The potential pathophysiological role of aldosterone and the mineralocorticoid receptor in anxiety and depression - Lessons from primary aldosteronism. (2020) (14)
Sepsis and cardiomyopathy as rare clinical manifestations of pheochromocytoma--two case report studies. (2010) (14)
Aged PROP1 Deficient Dwarf Mice Maintain ACTH Production (2011) (14)
Adrenal venous sampling guided adrenalectomy rates in primary aldosteronism: results of an international cohort (AVSTAT). (2020) (13)
Liposomal doxorubicin for active targeting: surface modification of the nanocarrier evaluated in vitro and in vivo — challenges and prospects (2015) (13)
Metabolic impact of pheochromocytoma/paraganglioma: Targeted metabolomics in patients before and after tumor removal. (2019) (13)
Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma (2015) (13)
Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism (2018) (13)
Targeting CXCR 4 ( CXC Chemokine Receptor Type 4 ) for Molecular Imaging of Aldosterone-Producing Adenoma (13)
Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus in the Russian population. (1997) (13)
Urocortin-1 and -2 double-deficient mice show robust anxiolytic phenotype and modified serotonergic activity in anxiety circuits (2010) (12)
Glucocorticoid Excess in Patients with Pheochromocytoma Compared with Paraganglioma and Other Forms of Hypertension (2020) (12)
Identification of adrenal genes regulated in a potassium-dependent manner. (2010) (12)
Clinical and molecular evidence for DAX-1 inhibition of steroidogenic factor-1-dependent ACTH receptor gene expression. (2005) (12)
Primary and Secondary Hyperparathyroidism in Patients with Primary Aldosteronism - Findings From the German Conn's Registry. (2019) (12)
Xenograft models for adrenocortical carcinoma (2016) (12)
Adrenomedullary function, obesity and permissive influences of catecholamines on body mass in patients with chromaffin cell tumours (2019) (12)
Progress in Primary Aldosteronism (2010) (12)
Treatment of Refractory Adrenocortical Carcinoma with Thalidomide: Analysis of 27 Patients from the European Network for the Study of Adrenal Tumours Registry. (2018) (12)
Heat Shock Protein 90 as a Prognostic Marker and Therapeutic Target for Adrenocortical Carcinoma (2019) (12)
Targeted Metabolomics as a Tool in Discriminating Endocrine From Primary Hypertension (2020) (12)
Differential effects of reduced mineralocorticoid receptor activation by unilateral adrenalectomy vs mineralocorticoid antagonist treatment in patients with primary aldosteronism - Implications for depression and anxiety. (2021) (11)
Genetics of adrenocortical tumours (2016) (11)
IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma (2016) (11)
Patients With Primary Aldosteronism Respond to Unilateral Adrenalectomy With Long-Term Reduction in Salt Intake (2019) (11)
Is there a role for the adrenal glands in long COVID? (2022) (11)
Prognostic value of histological markers in localized adrenocortical carcinoma after complete resection (2013) (11)
Primary Aldosteronism. (2019) (11)
Endocrine responses during CPAP withdrawal in obstructive sleep apnoea: data from two randomised controlled trials (2019) (11)
Hypokalemia and the Prevalence of Primary Aldosteronism (2020) (11)
Adrenocortical Tumorigenesis (2006) (11)
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma (2021) (10)
Changes in Body Mass Index in Pheochromocytoma Patients Following Adrenalectomy (2017) (10)
Spontaneous cerebrospinal fluid rhinorrhea in untreated macroprolactinoma--an indication for primary surgical therapy. (2006) (10)
A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome (2019) (10)
Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies. (2020) (10)
Beyond a Disease Registry: An Integrated Virtual Environment for Adrenal Cancer Research (2016) (10)
Perioperative Management of Endocrine Active Adrenal Tumors (2018) (10)
PBX1 is dispensable for neural commitment of RA-treated murine ES cells (2009) (10)
PRKACA Mutations in Adrenal Adenomas: Genotype/Phenotype Correlations (2016) (10)
Gender-, strain-, and inheritance-dependent variation in aldosterone secretion in mice. (2012) (10)
What Is the Optimal Duration of Adjuvant Mitotane Therapy in Adrenocortical Carcinoma? An Unanswered Question (2021) (10)
Missed clinical clues in patients with pheochromocytoma/paraganglioma discovered by imaging (2018) (9)
ENSAT Registry-Based Randomized Clinical Trials for Adrenocortical Carcinoma. (2020) (9)
Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients (2021) (9)
Circulating microRNA Expression in Cushing’s Syndrome (2021) (9)
The role of the ACTH receptor in adrenal tumors: identification of a novel microsatellite marker. (2004) (9)
Daily adjustment of glucocorticoids by patients with adrenal insufficiency (2019) (9)
567O First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): An academic double-blind trial investigating sunitinib (2021) (9)
Mc2 Receptor Knockdown Modulates Differentiation and Lipid Composition in Adipocytes (2012) (9)
Volumetric and densitometric evaluation of the adrenal glands in patients with primary aldosteronism (2017) (9)
Primärer Hyperaldosteronismus – Diagnostik und Therapie (2012) (9)
The Saline Infusion Test for Primary Aldosteronism: Implications of Immunoassay Inaccuracy (2021) (9)
Clinical Spectrum of Primary Adrenal Lymphoma: Results of a Multicenter Cohort Study. (2020) (9)
Oral glucose tolerance testing but not intravenous glucose administration uncovers hyper‐responsiveness of hypothalamo–pituitary–adrenal axis in patients with adrenal incidentalomas (2000) (8)
Regulation of human MC2-R gene expression by CREB, CREM, and ICER in the adrenocortical cell line Y1. (2007) (8)
Safety of medical adjustment and confirmatory testing in the diagnostic workup of primary aldosteronism. (2019) (8)
Genetic and Potential Autoimmune Triggers of Primary Aldosteronism (2015) (8)
Novel genes in primary aldosteronism (2014) (8)
Genetik und Pathophysiologie der Adipositas (2006) (8)
Growth hormone receptor mRNA expression in non-functioning and somatotroph pituitary adenomas: implications for growth hormone substitution therapy? (2005) (8)
Utilization of a mutagenesis screen to generate mouse models of hyperaldosteronism. (2011) (7)
The Adrenal Gland: Central Relay in Health and Disease (2019) (7)
Sleep quality in patients with primary aldosteronism. (2013) (7)
Decreased p44/42 mitogen-activated protein kinase phosphorylation in gender- or hormone-related but not during age-related adrenal gland growth in mice. (2009) (7)
Update endokrine Hypertonie (2018) (7)
Diagnosis: Novel molecular signatures for adrenocortical carcinoma (2009) (7)
Plasma steroid profiling in patients with adrenal incidentaloma. (2021) (6)
Targeting Pheochromocytoma/Paraganglioma with polyamine inhibitors. (2020) (6)
BEX1 Is Differentially Expressed in Aldosterone-Producing Adenomas and Protects Human Adrenocortical Cells From Ferroptosis (2021) (6)
Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study (2022) (6)
The natural history of adrenal incidentaloma - results from the international prospective multi-centre EURINE-ACT study (2017) (6)
Altered Taste Perception for Sodium Chloride in Patients With Primary Aldosteronism (2021) (6)
Patients with low IGF-I after curative surgery for Cushing's syndrome have an adverse long-term outcome of hypercortisolism-induced myopathy. (2021) (6)
Silencing Mutated b-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H 295 R (2013) (6)
Mouse models of adrenal tumorigenesis. (2010) (6)
CBP / p 300-Interacting Transactivator , with Glu / Asp-Rich C-Terminal Domain , 2 , and Pre-B-Cell Leukemia Transcription Factor 1 in Human Adrenal Development and Disease (2009) (6)
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells. (2017) (6)
Whom Should We Screen for Cushing Syndrome? The Endocrine Society Practice Guideline Recommendations 2008 Revisited (2022) (6)
Establishment of an in vivo model for KCNJ5 dependent hyperaldosteronism (2015) (6)
Referenz Endokrinologie und Diabetologie (2020) (6)
The tumor stem cell concept—Implications for endocrine tumors? (2009) (6)
The ubiquitin-specific peptidase 8 (USP8) gene is frequently mutated in adenomas causing Cushing's disease. (2015) (6)
Mechanistic Roles of Inhibin as a Tumor Suppressor in the Adrenal Cortex (2004) (5)
[Therapy-resistant hypertension--the endocrinological view]. (2007) (5)
Identification of risk loci for primary aldosteronism in genome-wide association studies (2022) (5)
Coexisting Prolactinoma and Primary Aldosteronism: Is There a Pathophysiological Link? (2015) (5)
Identification of glucocorticoid-related molecular signature by whole blood methylome analysis (2021) (5)
Biochemical diagnosis of pheochromocytoma using plasma free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions (2013) (5)
Progress in Primary Aldosteronism: Translation on the Move (2015) (5)
Urocortin-dependent effects on adrenal morphology, growth, and expression of steroidogenic enzymes in vivo. (2012) (5)
Animal models of primary aldosteronism. (2010) (4)
Adrenal and Ovarian Phenotype of a Tissue-Specific Urocortin 2-Overexpressing Mouse Model. (2015) (4)
Effects of chronically high levels of aldosterone on different cognitive dimensions: an investigation in patients with primary aldosteronism (2019) (4)
Clinical Impact of Recent Advances in the Biology of Adrenocortical Cancer (2003) (4)
Multicenter case series of primary adrenal lymphoma (2016) (4)
First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study. (2022) (4)
Impact of surgery on clinical outcome in patients with recurrence of adrenocortical carcinoma (2009) (4)
Virilization of a Young Girl Caused by Concomitant Ectopic and Intra-Adrenal Adenomas of the Adrenal Cortex (2013) (4)
Cytotoxic T-cell response against steroidogenic acute regulatory protein using DNA vaccination followed by vaccinia virus infection in a mouse adrenal carcinoma model. (2004) (4)
Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma. (2022) (4)
Metastatic pheochromocytoma and paraganglioma: signs and symptoms related to catecholamine secretion (2021) (4)
Genetic characterization of a mouse line with primary aldosteronism. (2017) (4)
Treatment of Primary Aldosteronism with mTORC1 Inhibitors. (2019) (4)
Whole blood methylome-derived features to discriminate endocrine hypertension (2022) (3)
Tinnitus With Unexpected Spanish Roots: Head and Neck Paragangliomas Caused by SDHAF2 Mutation (2019) (3)
Improved glucose tolerance after initiation of Elexacaftor / Tezacaftor / Ivacaftor in adults with cystic fibrosis. (2023) (3)
Progress in Primary Aldosteronism 2019: New Players on the Block? (2020) (3)
The adrenal X-zone is involved in progesterone inactivation (2006) (3)
Adrenal crisis and general morbidity in chronic adrenal insufficiency prospectively assessed in 472 patients (2011) (3)
Connshing syndrome - myth or reality? (2018) (3)
Tropomyosin receptor kinase: a novel target in screened neuroendocrine tumors. (2018) (3)
[Arterial hypertension and subclinical Cushing's syndrome]. (2010) (3)
The Diagnosis and Treatment of Primary Hyperaldosteronism in Germany (2009) (3)
Diagnostik einer endokrinenHypertonie: Wann screenen, und mit welchem Test? (2011) (3)
Mass Spectrometry Imaging Identifies Metabolic Patterns Associated with Malignant Potential in Pheochromocytoma and Paraganglioma. (2021) (3)
Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures. (2022) (3)
Adrenal Gland Function and Dysfunction During COVID-19. (2022) (3)
Sleep-EEG in patients with primary aldosteronism in comparison to healthy controls and patients with depression. (2019) (3)
Age below 40 or a recently proposed clinical prediction score cannot bypass adrenal venous sampling in primary aldosteronism: Results of the Else Kröner-Fresenius Hyperaldosteronismus Registry (2014) (3)
[Primary hyperaldosteronism: boundaries of diagnostics and therapy]. (2014) (3)
Urine steroid metabolomics as a diagnostic tool in primary aldosteroinism (2015) (3)
Inzidentalom und subklinische Funktionsstörungen der Nebenniere (2013) (3)
Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial (2022) (3)
Innovative multidimensional models in a high-throughput-format for different cell types of endocrine origin (2022) (3)
The role of adrenal venous sampling (AVS) in primary bilateral macronodular adrenocortical hyperplasia (PBMAH): a study of 16 patients (2022) (3)
[Diagnosis of endocrinological hypertension: when to screen, and by which method?]. (2011) (2)
Frequency and causes of adrenal crises over life-time in patients with 21-hydroxylase deficiency (2012) (2)
[Incidentaloma and subclinical disorders of the adrenal gland]. (2013) (2)
Pre- versus post-operative untargeted plasma nuclear magnetic resonance spectroscopy metabolomics of pheochromocytoma and paraganglioma (2021) (2)
Isolation of the side population (SP) from murine adrenal glands renders cells with adrenocortical stem cell properties (2007) (2)
Influence of cortisol cosecretion on non-ACTH stimulated adrenal venous sampling in primary aldosteronism: a retrospective cohort study. (2022) (2)
Investigating the Role of Cholesterol and Lipid Trafficking in Mitotane Resistance in Adrenocortical Carcinoma (2021) (2)
The side population phenomenon enriches for designated adrenocortical progenitor cells in mice. (2012) (2)
P-64 Decreased p44/42 MAPK phosphorylation in gender- or hormone-related but not during age-related adrenal gland growth in mice (2008) (2)
Somatic PRKACA mutations: association with transition from pituitary-dependent to adrenal-dependent Cushing's syndrome. (2019) (2)
Constitutive activation of PRKACA in adrenal Cushing's syndrome (2014) (2)
Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension (2022) (2)
Results of the ADIUVO trial, the first randomized study on post-operative adjuvant mitotane in patients with adrenocortical carcinoma (2021) (2)
Predicting Hypertension Subtypes with Machine Learning Using Targeted Metabolites and Their Ratios (2022) (2)
Adipositas – Klinische Bedeutung und Behandlungsstrategien (2011) (2)
Favorable long-term outcome of bilateral adrenalectomy in Cushing's disease (2014) (2)
Schon ein BMI von 25 sollte behandelt werden (2006) (2)
Somatic RET mutation in a patient with pigmented adrenal pheochromocytoma (2016) (2)
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma (2018) (2)
Primary aldosteronism: Diagnosis and differential diagnosis / Primärer Hyperaldosteronismus: Diagnose und Differentialdiagnose (2004) (2)
Targeted therapies in Pheochromocytoma and Paraganglioma. (2022) (2)
Urine steroid metabolomics is a highly sensitive tool for post-operative recurrence detection in adrenocortical carcinoma (2016) (2)
Endocrine responses during CPAP-withdrawal in obstructive sleep apnea: data from two randomised controlled trials (2019) (2)
cohort of 201 pheochromocytoma (2009) (2)
Adrenal tumours and hormone excess. Editorial. (2009) (1)
The German Conn's registry: comorbidities in over 700 patients with primary hyperaldosteronism (2008) (1)
[The basics of lysosomal storage diseases]. (2018) (1)
Pheochromocytoma/Paraganglioma is Associated with SDHx-mutations (2015) (1)
Expression and distribution of differentiation and proliferation markers during mouse adrenal development (2005) (1)
Neue Leitlinien zur Adipositas-Therapie : Schon ein BM1 von 25 sollte behandelt werden (2006) (1)
Supplementary data from:Adrenal venous sampling (AVS) in Primary Bilateral Macronodular Adrenocortical Hyperplasia (PBMAH): A study of 16 patients (2021) (1)
Mikro- und makronoduläre ACTH- unabhängige Nebennieren-Hyperplasie (2010) (1)
[Thyroid nodules--Indication for surgery?]. (2016) (1)
Progress in Primary Aldosteronism 2 (2012) (1)
Peroxisome proliferator activated receptor gamma (PPARγ) agonists suppress adrenocortical tumor cell proliferation and induce differentiation (2005) (1)
Die Grundlagen der lysosomalen Speicherkrankheiten (2018) (1)
CITED2 and PBX1 in human adrenal development and disease (2009) (1)
Prognostic value of DNA methylation in adrenocortical carcinomas: an ENSAT study (2014) (1)
Interdisziplinäres Management von Patienten mit malignem Phäochromozytom (2013) (1)
The metabolic phenotype of patients with primary aldosteronism: impact of subtype and sex - a multicenter-study of 3566 Caucasian and Asian subjects. (2022) (1)
Gonadectomized mice of the inbred strain CE/J develop adrenocortical tumors derived from subcapsular cells expressing x-zone marker (2004) (1)
Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer (2020) (1)
Prognostic factors of overall survival of stage III or IV adrenocortical carcinomas (ACC): A multicenter ENS@T study. (2014) (1)
Animal Models of Adrenal Genetic Disorders (2014) (1)
Anti-tumor activity of the tumor-vascular-disrupting agent ASA404 (vadimezan) in endocrine tumor models (2010) (1)
Preanalytical Pitfalls in Untargeted Plasma Nuclear Magnetic Resonance Metabolomics of Endocrine Hypertension (2022) (1)
Secondary causes of hypertension (2018) (1)
European Network for the Study of Adrenal Tumors: Adrenal Cancer Consortium (ENS@T-CANCER) (2011) (1)
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study (2023) (1)
[Genetics and pathophysiology of obesity]. (2006) (1)
Development of a novel anti-IGF1 receptor immunoliposomal cancer therapy with enhanced therapeutic efficiency (2009) (1)
Mitotane Targets Lipid Droplets to Induce Lipolysis in Adrenocortical Carcinoma (2022) (1)
Characteristics of preoperative steroid profiles and glucose metabolism in patients with primary aldosteronism developing adrenal insufficiency after adrenalectomy (2021) (1)
Nebennierenrindeninsuffizienz: Diagnostik und Therapie (1999) (1)
PRKACA somatic mutations are rare in aldosterone-producing adenomas. (2016) (1)
Sleep quality in patients with primary aldosteronism (2014) (1)
Mild autonomous cortisol excess in adrenal incidentalomas - metabolic disease burden and urinary steroid metabolome in 1201 prospectively recruited patients (2017) (1)
[Every eighth case of hypertension originates in the adrenal gland. For whom is it worthwhile to screen for an endocrine cause?]. (2010) (1)
[Fabry disease - the profile of an orphan disease]. (2018) (1)
Signs, symptoms and biochemistry in recurrent Cushing disease: a prospective pilot study (2021) (1)
[ 123 I]Iodometomidate as a radiotracer for adrenal scintigraphy first clinical experience (2007) (1)
Abstract 2976: Comprehensive Pan-Genomic characterization of adrenocortical carcinoma (2015) (1)
SARS-CoV-2 infection and its effects on the endocrine system (2023) (1)
Time from symptoms to diagnosis in Cushing's syndrome: results of the German Cushing Registry in Munich (2014) (1)
The –2 basepair initiation start site ACTH receptor polymorphism influences ACTH induced adrenal androgen secretion (2005) (0)
Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma (2023) (0)
Review: A critical re-appraisal of bilateral adrenalectomy for ACTH- (2015) (0)
Triple CFTR modulator therapy is associated with improved endocrine pancreatic function in patients with cystic fibrosis (2022) (0)
Investigation of novel chemotherapeutic combinations in a tumor model of adrenocortical carcinoma (2013) (0)
SUN-LB97 Targeted Metabolomics as a Screening Tool in the Diagnosis of Endocrine Hypertension (2020) (0)
PRKACA mutations in adrenal Cushing impair association with the PKA regulatory subunit (2016) (0)
Deoxyguanosine kinase mutation F180S is associated with a lean phenotype in mice (2023) (0)
Remission, recurrence and control rates in patients with ACTH-dependent Cushing's syndrome- a monocentric, retrospective analysis (2016) (0)
Urinary steroid profiling demonstrates induction of CYP3A4 and inhibition of 5alpha-reductase by mitotane treatment for adrenocortical carcinoma (2012) (0)
Identification of a molecular signature of hypercortisolism by whole blood methylome analysis (2019) (0)
Acknowledgement to referees (2006) (0)
Repeated immunoliposomal treatment of endocrine tumors (2015) (0)
[Obesity 2006]. (2006) (0)
MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors (2020) (0)
Treatment of refractory adrenocortical carcinoma with thalidomide: results of a retrospective analysis of 15 patients (2014) (0)
Investigation of novel chemotherapeutic combinations in a tumor model for adrenocortical carcinoma (2013) (0)
Moderators of the psychotropic effect of aldosterone in primary aldosteronism (2019) (0)
Primary aldosteronism and the occurrence of hyperparathyroidism in the German Conn's registry (2015) (0)
Human Cancer Biology MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma (2012) (0)
P-39 ANALYSIS OF THE IGF-SYSTEM AND GH/IGF-DEPENDENT SIGNALING CASCADES DURING GROWTH AND DEVELOPMENT OF THE ADRENAL GLAND (2006) (0)
University of Birmingham Constitutive activation of PKA catalytic subunit in Adrenal Cushing's Syndrome (2014) (0)
RF21 | PSAT77 ROLE OF THE TRANSCRIPTION FACTOR HHEX IN INNER ADRENAL CORTEX HOMEOSTASIS AND RESPONSE TO PROGESTERONE SIGNALING (2022) (0)
Editorial: The adrenal gland: central relay in health and disease (2019) (0)
Cofilin is a cAMP effector in mediating actin cytoskeleton reorganization and steroidogenesis in mouse and human adrenocortical tumor cells (2017) (0)
Acknowledgement to Reviewers (2009) (0)
The epoxyeicosatrienoic pathway is intact in endothelial and smooth muscle cells exposed to aldosterone excess (2021) (0)
Arterial Hypertension (2021) (0)
Muscle strength in Cushing's syndrome: cross-sectional evaluation of the German Cushing's registry (2016) (0)
Cardiometabolic disease burden and urine steroid metabolome in benign adrenocortical tumours: a case-control study (2021) (0)
Recurrent somatic mutations in Ying Yang 1 (YY1) are found in a subgroup of sporadic insulinomas (2015) (0)
SUN-381 Somatic PRKACA Mutations In Patients With Transition From Pituitary-dependent To Adrenal-dependent Cushing’S Syndrome (2019) (0)
tandem mass spectrometry : utility for diagnosis of dopamine-producing metastatic − chromatography Analysis of plasma 3-methoxytyramine , normetanephrine and metanephrine by ultraperformance liquid (2013) (0)
Health-Related Quality of Life in Fabry Disease: A Cross-sectional International Multicenter Study (2021) (0)
Results of transsphenoidal surgery for Cushing's disease in a contemporary series (2006) (0)
Differential expression of protein kinase A catalytic and regulatory subunits in adrenocortical adenomas (2016) (0)
Armadillo repeat containing 5 gene (ARMC5) alterations in a large cohort of 98 ACTH-independant macronodular adrenal hyperplasia (AIMAH) patients: genotype/phenotype correlations. (2014) (0)
Incidence of Primary Aldosteronism in Patients with Hypokalemia (IPAHK+): Study Design and Baseline Characteristics (2021) (0)
Identification of clinical parameters predictive of ARMC5 mutation in a large cohort of primary bilateral macronodular adrenal hyperplasia (PBMAH) patients. (2020) (0)
Targeted molecular markers derived from genomic classification for adrenocortical cancer prognostication (2017) (0)
BMP dependent effects on adrenal tumorigenesis and function (2007) (0)
Differential TNF[alpha] -synthesis and signaling in endocrine tumors after treatment with the Tumor-Vascular-Disrupting Agent ASA404 (vadimezan) (2012) (0)
Differential expression of the PKA subunits in adrenocortical adenomas (2015) (0)
Life-threatening emergencies in patients with pheochromocytoma (2013) (0)
Associations of different hormonal contraceptive methods with hair concentrations of cortisol, cortisone, and testosterone in young women (2022) (0)
Expression of prolactin receptor in aldosterone-producing adrenal adenomas (2014) (0)
COVID-19 in Fabry disease: a reference center prospective study (2022) (0)
Outcome of patients with adrenocortical cancer after discontinuation of adjuvant mitotane therapy (2017) (0)
Investigation of a novel liposomal chemotherapy protocol in three preclinical models for adrenocortical carcinoma in vivo (2015) (0)
[Adrenal cortex insufficiency: diagnosis and therapy]. (1999) (0)
Management of adrenal crisis – targets, limits and realities (2014) (0)
k G, Reincke zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. (1970) (0)
Site specific overexpression of urocortin 2 results in modulation of steroidogenesis in vivo (2011) (0)
Calcineurin-NFATc4 Pathway Is Activated Upon K+-stimulation of Adrenal Aldosterone Production (2021) (0)
DIFFERENTIAL DIAGNOSIS OF PRIMARY ALDOSTERONISM SUBTYPES USING ADRENAL VEIN SAMPLING: EVALUATION OF THE GERMANS CONNʼS REGISTRY: 4D.07: (2010) (0)
Development and characterisation of patient-individual tumor models for endocrine tumors (2011) (0)
Early post-operative ACTH-stimulated aldosterone predicts long-term biochemical outcome in primary aldosteronism (2022) (0)
BMP dependent modulation of adrenocortical growth and function (2008) (0)
[Autonomous cortisol secretion : Laboratory artifact or disease?] (2021) (0)
Screening for peptide hormone receptor expression in primary aldosteronism (2007) (0)
[123I]Iodometomidate as a radiotracer for adrenal scintigraphy – first in vivo experience (2007) (0)
Female patients with primary aldosteronism are diagnosed earlier and have a better cardiovascular outcome after treatment (2013) (0)
The endocrine society practice guideline revisited: why do nowadays patients undergo screening for cushing' syndrome, and with which outcome? (2022) (0)
Immunophenotypic differences in patients with primary adrenal insufficiency of different etiology (2023) (0)
Circular RNA-based biomarkers in blood of patients with Fabry disease and related phenotypes (2021) (0)
Acknowledgment of Reviewers, 2019 (2019) (0)
Plasma metabolomics profile in patients with Cushing's syndrome (2016) (0)
New germline mutation in CACNA1H calcium channel causing primary aldosteronism (2016) (0)
Mc2 receptor in adipocytes is significant for lipid composition and regular lipolysis (2009) (0)
Towards an aldosterone producing cell line from an aldosterone producing adenoma (2009) (0)
Female patients with primary aldosteronism are diagnosed earlier and have a better outcome (2012) (0)
Dopamine agonist-responsive Cushing’s disease (2019) (0)
Abstract 4059: The bone morphogenic protein 7 (Bmp7) plays a pro-tumorigenic role in pheochromocytoma (2014) (0)
Clinical and biochemical outcome after unilateral adrenalectomy in primary aldosteronism (2015) (0)
Demographics of adrenal incidentaloma - results from an international prospective multi-centre study in 2190 patients (2016) (0)
Protein Kinase A signaling saves regulatory subunit II[beta] from PRKACA mutation-mediated degradation (2017) (0)
Identification of genes mediating dysregulated cell growth in aldosterone-producing adenomas (2019) (0)
MUC-1: update on a newly established tumor model for adrenocortical carcinoma (2016) (0)
Mass spectrometry-based adrenal venous steroid profiling for subtyping primary aldosteronism (0)
Differential TNF[alpha] and Toll-like-receptor 4-signaling in endocrine tumors after tumor- vascular- disrupting Agent ASA404 (Vadimezan) and TNF[alpha] treatment (2014) (0)
MicroRNAs as endogenous modulators of glucocorticoid receptor expression in the adrenal gland after ACTH stimulation test (2011) (0)
Molecular pathogenesis of adrenocortical tumors (2009) (0)
Management and outcome of pregnancies in women with adrenal insufficiency: experience from a retrospective European study (2019) (0)
University of Birmingham Somatic PRKACA mutations Birmingham portal (2019) (0)
The influence of surgery in the management of recurrent adrenocortical carcinoma. (2012) (0)
Adrenale Hypertonieformen Von der Diagnose zur Therapie (2006) (0)
Ektope Hormonsekretion bei neuroendokrinen Tumoren Schwerpunktherausgeber (2012) (0)
Morbus Gaucher – ein Überblick über eine Sphingolipidose (2018) (0)
Ab wann muss eine Schilddrüsenüberfunktion behandelt werden? (2008) (0)
Therapiealgorithmus bei Patienten mit malignem Phäochromozytom (2013) (0)
Therapieresistente Hypertonien sind häufig hormonbedingt (2007) (0)
CME-Antworten : zu den Fragen zu «Rationale Abklärungsstrategie bei einem Nebenniereninzidentalom» aus Praxis Nr. 19 (2017) (0)
Endokrinologie und Diabetologie: Primärer Hyperaldosteronismus – was können wir besser machen? (2017) (0)
Kapitel 2 – Endokrinologie (2013) (0)
Intrakranielle Hypertension – und was macht der Blutdruck? (2020) (0)
Morbus Fabry – das Porträt einer seltenen Erkrankung (2018) (0)
Diagnostik und Therapie endokriner Hochdruckformen – Primärer Hyperaldosteronismus, Hyperkortisolismus und Katecholaminexzess (2009) (0)
Schilddrüsenknoten: wann operieren? (2016) (0)
Primärer Hyperaldosteronismus – wo liegen die Grenzen der Diagnostik und Therapie? (2014) (0)
KAPITEL 17 – Endokrine Erkrankungen (2009) (0)
Korrelation zwischen Nebennierenmorphologie und kardiovaskulären Parametern (2015) (0)
Primärer Hyperaldosteronismus und Hypokaliämie (2021) (0)
Knochenumbaumarker bei Cushing-Patienten im longitudinalen Verlauf (2020) (0)
Das Cushing-Syndrom: Diagnostik und Therapie (1999) (0)
Häufigkeit und Ursachen von Nebennierenkrisen bei Patienten mit Adrenogenitalem Syndrom (2014) (0)
Endokrine Probleme nach allogener hämatologischer Stammzelltransplantation (2001) (0)
Bei wem lohnt das Screening auf eine endokrine Ursache? (2010) (0)
Inzidentalom und subklinische Funktionsstörungen der Nebenniere (2013) (0)
CME: Rationale Abklärungsstrategie bei einem Nebenniereninzidentalom (2017) (0)
Neuroendokrine Tumoren des gastroenteropankreatischen Systems (2012) (0)
The Vault Complex Is Significantly Involved in Therapeutic Responsiveness of Endocrine Tumors and Linked to Autophagy under Chemotherapeutic Conditions (2023) (0)
Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia (2023) (0)
β-Catenin and FGFR2 regulate postnatal rosette-based adrenocortical morphogenesis (2020) (0)
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST” (Taper Or Abrupt Steroid STop) multicenter trial (2023) (0)
Functional Implications of PRKACA Somatic Mutations (2017) (0)
Diagnostic and therapeutic challenges in cyclic Cushing's syndrome: A systematic literature review (2023) (0)
Low-grade inflammation during the glucocorticoid withdrawal phase in patients with Cushing's syndrome. (2023) (0)
Metastatic pheochromocytoma and paraganglioma: Somatostatin receptor 2 expression, genetics and therapeutic responses. (2023) (0)
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma (2023) (0)
Pregnancy outcomes in women with classic and non-classic congenital adrenal hyperplasia (2023) (0)
Poor adherence of patients with chronic adrenal insufficiency to medical advice in daily life (2015) (0)
Triiodothyronine supplementation improves lipid parameters in central hypothyroidism: a randomized controlled trial ('4 T study') (2005) (0)
Animal models of primary aldosteronism. (2009) (0)
Increased risk of cardiometabolic disease in patients with benign adrenal tumours with and without cortisol excess: a casecontrol study (2021) (0)
International multicenter survey on screening and confirmatory testing in primary aldosteronism. (2023) (0)
PRKACA mutations in adrenal Cushing can alter substrate specificity (2017) (0)
Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples – preparation for an international adrenal tumor bank (2006) (0)
Immunoexpressions of CYP11B2 and HSD3B2 in genetically characterised aldosterone producing adenomas (2015) (0)
Effectiveness of eplerenone or spironolactone treatment and adrenalectomy regarding renal function in male patients with primary aldosteronism (2011) (0)
Anxiety and depressive symptoms in patients with primary aldosteronism in a longitudinal study (2012) (0)
Assessment of VAV 2 expression refines prognostic prediction � . 3 in adrenocortical carcinoma � (0)
The Role of Inhibin and Activin in Adrenal Tumorigenesis (2004) (0)
Genomic approach to management of adrenal tumours (2017) (0)
Lack of sensitivity of diagnostic Cushing-scores in Germany: a multicenter validation. (2023) (0)
Genetics of primary aldosteronism (2013) (0)
Acknowledgement to Referees (2005) (0)
RNA-sequencing of adrenocortical tumors reveals novel pathogenetic insights (2020) (0)
OR29-2 Mild Autonomous Cortisol Excess (MACE) in Adrenal Incidentalomas - Metabolic Risk Profile and Urinary Steroid Metabolome Analysis in 1208 Prospectively Recruited Patients (2019) (0)
PF311 ISOLATED PRIMARY ADRENAL LYMPHOMA (IPAL) - AN EMERGING LYMPHOMA ENTITY? RESULTS OF A RETROSPECTIVE MULTICENTER STUDY (2019) (0)
Preoperative pegvisomant as a potential therapeutic option to improve cardiac function in Acromegaly-induced cardiomyopathy: Two cases (2020) (0)
Reduced fertility rates and high prevalence of testicular adrenal rest tumors (TART) in male patients with congenital adrenal hyperplasia (2008) (0)
P02-40 Anti-IGF1 receptor immunoliposomes: A single formulation combining two anticancer treatments with enhanced therapeutic efficiency (2012) (0)
Establishment of patient-individual tumor models for endocrine tumors (2013) (0)
Zona glomerulosa derived Klotho does not regulate aldosterone synthesis in young mice (2021) (0)
Beyond a Disease Registry: An Integrated Virtual Environment for Adrenal Cancer Research (2016) (0)
A role for vault particles as mediator for therapeutic effects against endocrine tumors (2015) (0)
Cell cycle progression score as a predictive biomarker for overall survival in patients with adrenocortical carcinoma (2020) (0)
Steroidogenic factor 1 - a valuable diagnostic and prognostic tool in patients with adrenocortical carcinoma (2009) (0)
Comparison of strategies for biochemical diagnosis of primary aldosteronism in German academic centres (2008) (0)
Characteristics of aldosterone-producing adenomas: a tissue microarray study (2017) (0)
MUC-1 – a novel preclinical model for adrenocortical carcinoma? (2014) (0)
Author response for "The effect of biochemical remission on bone metabolism in Cushing's syndrome: a two‐year follow‐up study" (2020) (0)
Endocrine disorders in patients with Fabry Disease: A comprehensive reference center study (2021) (0)
Identification d’une signature moléculaire d’hypercortisolisme par analyse du methylome du sang total (2020) (0)
Long-term outcome of laparoscopic versus open adrenalectomy for adrenocortical carcinoma (2009) (0)
Urine steroid metabolomics as a novel diagnostic tool for recurrent adrenocortical carcinoma detection (2019) (0)
BMP5 treatment of adrenocortical carcinoma delays tumor growth via activation of endogenous anti-tumoral macrophages (2013) (0)
Dose interval comparison of Lanreotide Autogel 120 mg in acromegalic patients previously treated with Octreotide LAR (2009) (0)
Are Anxiety and Depression Mediated by Different Mineralocorticoid Receptor Pathways? Results From Primary Aldosteronism (2021) (0)
Diagnosing Vasopressin Deficiency (Central Diabetes Insipidus) using Copeptin following Hypertonic Saline and Arginine Stimulation (2023) (0)
Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples preparation for an European adrenal tumor bank (ENS@T) (2006) (0)
[Obesity - clinical impact and therapeutic strategies]. (2011) (0)
[Gaucher's disease - an overview about a sphingolipidosis]. (2018) (0)
Response Letter to the Editor from Sweeney AT: "CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma". (2020) (0)
Awareness & participation in rare disease registries within the European reference network on rare endocrine conditions (Endo-ERN) (2018) (0)
methoxytyramine spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass (2013) (0)
Hypercortisolism-related molecular signature: Results from whole blood methylome analysis (2020) (0)
The epoxyeicosatrienoic pathway is intact in endothelial and smooth muscle 1 cells exposed to aldosterone excess 2 Short title : Intact EET pathway in hyperaldosteronism 3 (2021) (0)
Primary aldosteronism – prevalence and prognosis in primary care (2014) (0)
MUC-1 - a novel preclinical model for adrenocortical carcinoma (2014) (0)
General morbidity and working capacity in patients with chronic adrenal insufficiency – A prospective study (2015) (0)
Steroid and global metabolome in benign adrenal tumours with mild autonomous cortisol secretion: analysis by mass spectrometry and machine learning to understand metabolic risk (2022) (0)
Clonal Composition of Human Adrenocortical Neoplasms 1 (2006) (0)
Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism following adrenalectomy (2012) (0)
Extensive preclinical screening of chemotherapeutic agents and molecular targeted Inhibitors reveals potent combinatory treatment for adrenocortical carcinoma (ACC) (2021) (0)
OR34-02 Somatic Transmembrane Domain Mutations of a Cell Adhesion Molecule, CADM1, Cause Primary Aldosteronism by Preventing Gap Junction Communication Between Adrenocortical Cells (2019) (0)
GLUCO- AND MINERALOCORTICOIDS SYNERGISTICALLY DOWNREGULATE BKCA CHANNEL TRANSCRIPTION IN VASCULAR SMOOTH MUSCLE CELLS BUT DO NOT AFFECT THE EPOXYEICOSATRIENOIC ACID PATHWAY (2021) (0)
Canakinumabin patients with COVID-19 and type 2 diabetes (CanCovDia) - a multicentric, randomised, double-blind, placebo-controlled phase 3 trial (2022) (0)
Low SLC26A2 expression in adrenal cells is associated with high aldosterone output (2012) (0)
MON-380 Tinnitus with Unexpected Spanish Roots: Head and Neck Paragangliomas Caused by SDHAF2 Mutation (2019) (0)
Influence of antihypertensive medication on the screening parameter aldosterone to renin ratio in patients with essential hypertension and primary aldosteronism (2014) (0)
Liposome based strategies for the treatment of adrenocortical carcinoma (2011) (0)
High levels of ACTH can restore adrenal morphology and function in POMC knock out mice (2005) (0)
Novel Distributed Informatics Platform to Support Machine Learning Discovery of Metabolic Biomarkers in Hypoxia Predisposition (2023) (0)
Acknowledgment to Reviewers (2020) (0)
The national Conn's registry: Objectives and first results (2007) (0)
First phase insulin secretion is impaired by aldosterone excess in primary aldosteronism (2013) (0)
In Situ Metabolomics of Cortisol-Producing Adenomas. (2022) (0)
Potassium channels in primary aldosteronism (2012) (0)
Aldosterone Insufficiency Contributes to Calcineurin Inhibitor‐induced Hyperkalemia (2021) (0)
46,Xy Dsd Caused by a De Novo Missense Mutation in the Tale Homedomain of Pbx1 (2017) (0)
Cardiovascular outcome in patients with primary aldosteronism following adrenalectomy and mineralocorticoid antagonist treatment: prospective results of the Munich Conn Center (2014) (0)
Regulation of ACTH-R gene expression by CREB, CREMt and ICER in the adrenocortical cell line Y1 (2005) (0)
ATP2B3, and KCNJ5 Mutations in Aldosterone-Producing Adenomas (0)
Characterization of Stem Cell Markers in Pheochromocytomas and Paragangliomas (2014) (0)
SAT-LB23 Paraneoplastic Hypercalcemia in a PTH Producing Adrenocortical Carcinoma - a Rare and Deadly Condition (2020) (0)
Adrenal phenotype in TPIT insufficient animals cannot be restored by short-term treatment with physiological doses of ACTH and N-POMC (2005) (0)
Subtype differentiation in primary hyperaldosteronism: evaluation of alternative algorithms avoiding a controversial gold standard (2010) (0)
Endocrine disorders in patients with Fabry disease: insights from a reference centre prospective study (2021) (0)
Proneuropeptide Y and neuropeptide Y metabolites in healthy volunteers and patients with a pheochromocytoma or paraganglioma. (2022) (0)
Mechanisms and consequences of endocrine autonomy - lessons learned from the adrenal cortex (2019) (0)
Obstructive sleep apnea in primary aldosteronism is associated with cortisol cosecretion (2020) (0)
Role of GLUT-2 expression and MGMT methylation for streptozotocin clinical response in adrenocortical carcinoma (2018) (0)
[Neuroendocrine tumors of the gastroenteropancreatic system. An interdisciplinary challenge]. (2012) (0)
Machine Learning models for the accurate prediction of malignant pheochromocytomas and paragangliomas (2022) (0)
Metabolic and inflammatory parameters for baseline characterization and treatment outcome of prolactinoma patients (2022) (0)
Post saline infusion test aldosterone levels indicate severity and outcome in primary aldosteronism (2014) (0)
ACTH receptor promoter polymorphism associated with a decrease in adrenal responsiveness to ACTH – in vitro and in vivo characterization (2004) (0)
Characterization of transcriptional and miRNA based dysregulations in Cushing's syndrome (2021) (0)
[123I]Iodometomidate as a radiotracer for diagnosis of adrenal tumours and adrenocortical carcinoma (2008) (0)
Diurnal Salivary Cortisol Profiles in Patients with Cushing's Syndrome. (2022) (0)
Somatic mutations in USP8 are frequent events in pituitary tumors causing Nelson's syndrome (2017) (0)
Molecular classifiers refine the prognostic stratification of adrenocortical carcinoma (2018) (0)
Role of KCNJ5 mutations in mediating cell growth in aldosterone-producing adenomas (2019) (0)
Glucocorticoid production in primary aldosteronism - from mechanisms to clinical implications (2017) (0)
Identification and stratification of pheochromocytomas/paragangliomas with SDHx mutations using the succinate to fumarate ratio (2014) (0)
Establishment of a mutagenesis screen to identify mice with high aldosterone levels (2008) (0)
[OP.3A.06] LONG TERM FOLLOW-UP IN PATIENTS OPERATED ON A PHEOCHROMOCYTOMA OR A PARAGANGLIOMA: COMPILATION OF THE ENS@T DATABASE (2016) (0)
Reduction of steroid replacement therapy in patients with congenital adrenal hyperplasia in the transition period from child- to adulthood (2007) (0)
Identification and characterization of the adrenal tumor side population (2007) (0)
Differential TNFα and Toll-like-receptor 4-signaling in endocrine tumors after tumor-vascular-disrupting agent ASA404 (vadimezan) and TNFα treatment (2014) (0)
Spatio-temporal expression of the ACTH receptor during mouse adrenal development: Implication for adrenal growth and differentiation (2004) (0)
Expression and mutational status of USP8 in tumours causing ectopic Cushing's syndrome (2016) (0)
Prevalence and clinical correlates of CACNA1D mutations in primary aldosteronism (2014) (0)
Renal function in patients with primary aldosteronism: comparison with essential hypertension (2008) (0)
Effects of CPAP treatment on sex hormone levels in patients with obstructive sleep apnoea - data from two randomized, controlled trials (2019) (0)
CAV1.3, HSD3B2 and CYP11B2 immunoexpressions in aldosterone-producing adenoma are not correlated with post-adrenalectomy outcome in primary aldosteronism (2015) (0)
Intact endothelial epoxyeicosatrienoic acids pathway in primary aldosteronism – the route to new treatment strategies? (2020) (0)
Cardiovascular morbidity in patients with suspected Cushing's syndrome. A prospective evaluation of the German Cushing's registry (2015) (0)
Urine steroid metabolomics as a novel diagnostic tool for early detection of recurrence in adrenocortical carcinoma (2015) (0)
High-sensitive C-reactive protein in primary aldosteronism Reply (2017) (0)
Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess (2019) (0)
Targeting mutated [beta]-catenin in vitro and in vivo inhibits cell proliferation and stimulates apoptosis: a promising therapeutic target in adrenocortical carcinoma (2012) (0)
[A common hormonal imbalance with a wide clinical spectrum. When must hyperthyroidism be treated?]. (2008) (0)
Influence of somatic mutations on the lateralization index of adrenal vein sampling in aldosterone producing adenomas (2013) (0)
n euroendocrine Tumor r ecurrence: Diagnosis with 68 Ga-DOTATATE PET/CT 1 (2014) (0)
A functional polymorphism at the transcription initiation site of the ACTH receptor gene associated with lower responsiveness to ACTH (2007) (0)
Differential expression of the protein kinase A subunits in normal adrenal glands and adrenocortical adenomas (2017) (0)
Prospective prediction of germ line mutations in patients with pheochromocytomas and paragangliomas according to biochemical profiles (2015) (0)
Prolactinoma and primary aldosteronism: is there a causal link? (2015) (0)
Time to diagnosis in Cushing’s syndrome: Impact of subtypes and gender (2019) (0)
Advances in genetic causes of adrenal Cushing's (2015) (0)
Smoc1, Mtus1 and Gpr48 are regulated in potassium dependent aldosterone secretion (2007) (0)
Characterization of a mouse model with mutagenesis induced hyperaldosteronism (2009) (0)
Focal DNA methylation measurement in adrenocortical carcinoma is a prognostic marker independent from tumor stage and Ki67; an ENSAT study (2016) (0)
The European Journal of Endocrinology Prize Winner (2013) (0)
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients (2018) (0)
Subject Index Vol. 68, Suppl. 5, 2007 (2007) (0)
[Cushing syndrome: diagnosis and therapy]. (1999) (0)
Is steroid profiling using LC-MS/MS useful in the diagnostic work-up of primary aldosteronism? (2016) (0)
A mouse model with hyperaldosteronism carrying an ENU induced mutation on chromosome 9 (2010) (0)
Autonome Kortisolsekretion (2021) (0)
Update endokrine Hypertonie (2019) (0)
Diagnosis and Treatment of Primary Aldosteronism in 2017: Did We Achieve Our Goals? (2017) (0)
ACTH-Receptor-initiated Signaling in Adrenal Tumorigenesis (2004) (0)
OR34-04 Efficiency of Adrenal Venous Sampling in the Treatment Choice of Primary Aldosteronism (AVSTAT Study) (2020) (0)
Screening for aberrant peptide hormone responsiveness in primary aldosteronism (2008) (0)
Deficits in the clinical management of patients with adrenocortical carcinoma in Germany (2008) (0)
A role for vault particles as a marker for therapeutic effects against endocrine tumours (2015) (0)
Eighteenth Conference on the Adrenal Cortex Munich, Germany June 25–27, 2018 (2019) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Felix Beuschlein?

Felix Beuschlein is affiliated with the following schools:

University of Freiburg
Ludwig Maximilian University of Munich
University of Regensburg
University of Michigan
University of Turin
University of Würzburg
University of Zurich